Research analysts at Maxim Group began coverage on shares of Medicus Pharma (NASDAQ:MDCX – Get Free Report) in a report released on Tuesday,Benzinga reports. The firm set a “buy” rating and a $10.00 price target on the stock. Maxim Group’s price objective points to a potential upside of 332.90% from the stock’s previous close.
Medicus Pharma Stock Down 12.5 %
Medicus Pharma stock opened at $2.31 on Tuesday. Medicus Pharma has a 12-month low of $1.80 and a 12-month high of $6.00.
About Medicus Pharma
Recommended Stories
- Five stocks we like better than Medicus Pharma
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Use the MarketBeat Dividend Calculator
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- The 3 Best Blue-Chip Stocks to Buy Now
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
